HCW Biologics Inc. (HCWB) vs Silexion Therapeutics Ltd. (SLXN)
A side-by-side comparison of HCW Biologics Inc. and Silexion Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HCWB
HCW Biologics Inc.
$1.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SLXN
Silexion Therapeutics Ltd.
$0.26HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — HCWB vs SLXN
growth of $100 · dividends reinvested · last 2yHCWB -98.6% (-88.3%/yr)SLXN -100.0% (-99.0%/yr)HCWB compounded faster over this window
Log scale — wide-divergence pair
HCWB SLXN
HCWB vs SLXN: by the numbers
- •HCWB is the larger company ($545796 vs $110112 market cap).
- •Both run net losses; SLXN's is the smaller (0.00% vs -73.22% net margin).
Metrics side by side
Valuation
| Metric | HCWB | SLXN |
|---|---|---|
| P/S ratio | 0.08 | N/A |
| P/B ratio | 0.07 | 2.50 |
Profitability
| Metric | HCWB | SLXN |
|---|---|---|
| Gross margin | 20.00% | 0.00% |
| Operating margin | -20757.65% | 0.00% |
| Net margin | -73.22% | 0.00% |
| ROE | -66.26% | -31722.73% |
| ROIC | -41.92% | N/A |
Growth (annualized)
| Metric | HCWB | SLXN |
|---|---|---|
| Revenue CAGR (5Y) | -57.90% | N/A |
| Total return CAGR (5Y) | -69.71% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.